N
NEXORAPHARMA
Basel, Switzerland · Est. 2019

The Research Peptide Company
That Doesn't Cut Corners.

Nexora Pharma was built on a simple belief: researchers deserve compounds that perform exactly as the science predicts. Not approximately. Not "close enough." Exactly.

13+
Active Compounds
50+
Countries Served
≥99%
Purity Standard
3rd Party
Lab Verified

Why Nexora Exists

The peptide research market was — and still is — flooded with suppliers who treat purity as an aspiration rather than a standard. Researchers were getting compounds that tested at 85%, 90%, occasionally 95% — and paying for 99%.

We founded Nexora to fix that. Every compound we supply comes with a third-party Certificate of Analysis. If a batch doesn't hit ≥99% — it doesn't ship.

That's not a marketing claim. It's a policy. And it's why institutions across 50+ countries trust Nexora to supply their most critical research.

View Our Catalog

Our Quality Commitment

HPLC purity analysis on every batch
Mass spectrometry molecular verification
Independent third-party laboratory testing
Certificate of Analysis with every order
Batch-to-batch reproducibility guaranteed
Temperature-controlled storage & shipping

What We Stand For

Science First, Always

Every compound in our catalog is selected on the basis of peer-reviewed research — not marketing trends. If the science isn't there, neither are we.

Uncompromising Quality

≥99% purity isn't a goal — it's a floor. Every batch undergoes HPLC and mass spectrometry verification by an independent third-party lab before it ships.

Global Research Access

Premium research compounds shouldn't be gatekept by geography or institutional size. We supply to universities, biotech startups, and independent researchers equally.

Researcher Relationships

We don't process orders — we build research partnerships. Our team includes scientists who understand your work because they've done similar work themselves.

Our Journey

19
2019

Founded in Basel, Switzerland with a focus on recovery and healing peptides

20
2020

First international shipments to EU research institutions; 99% purity standard established

21
2021

Expanded catalog to metabolic and performance compounds; third-party testing partnership formalized

22
2022

Launched longevity research line including NAD+ and Epitalon; 20+ countries served

23
2023

Full hormonal wellness catalog launched; institutional account program introduced

24
2024

50+ countries served; ISO-compliant logistics infrastructure completed

25–26
2025–26

Expanded to 13 compounds across 5 research categories; white-label program launched

Ready to Elevate Your Research?

Join 500+ research institutions worldwide who trust Nexora for their peptide supply.